Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRD2 polymorphisms and clozapine response in schizophrenia
ChiCTR-TNRC-11001290Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Oct 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clozapine in schizophrenia (5 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoint: PANSS scale. Started Oct 2006; status: completed.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-TNRC-11001290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-11001290.